Essential role of high concentrations of interleukin-2 to maintain growth and functions of human interleukin-2-activated natural killer cells

被引:0
|
作者
Nagashima, S [1 ]
Morikawa, H [1 ]
Yoda, N [1 ]
Niwa, A [1 ]
机构
[1] Dokkyo Univ, Sch Med, Dept Microbiol, Mibu, Tochigi 3210293, Japan
来源
INTERNATIONAL JOURNAL OF IMMUNOTHERAPY | 2000年 / 16卷 / 1-2期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated the effects of interleukin-2 (IL-2) on growth and cytotoxicity functions of human natural killer (NK) cells in culture. it is weil known that a high dose of IL-2 is necessary to develop IL-2-activated NK (A-NK) cells from human lymphocytes at an early stage in culture. After culture in the presence of 6,000 IU/ml of IL-2 for 10 days, A-NK cells were further incubated with or without 6,000 IU/ml of IL-2 for 48-96 h. Growth of A-NK cells was dependent on the presence of IL-2. Elimination of IL-2 resulted in the down-regulation of IL-2 receptor alpha -chain expression and the up-regulation of that of the beta -chain on A-NK cells. A-NK cells incubated with IL-2 had increased expression of Fas ligand and CD56, CD54 and CD11a molecules compared with the cells incubated without IL-2. A-NK cells incubated without IL-2 secreted both tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma in significantly lower amounts than those secreted by the cells incubated with IL-2. After incubation with IL-2, A-NK cells showed that the cytolytic activity against NK-sensitive K-562 targets was significantly higher than that of A-NK cells after incubation without IL-2. While A-NK cells after incubation with IL-2 also lysed NK-resistant HR targets, the cells incubated without IL-2 did not. in addition, A-NK cells after incubation with IL-2 induced DNA fragmentation in HR targets significantly more than in A-NK cells after incubation without IL-2. This study demonstrates that a high dose of IL-2 is necessary to maintain growth and some antitumor activities of A-NK cells.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 50 条
  • [1] Cancer immunotherapy with interleukin-2-activated natural killer cells
    Basse, PH
    Whiteside, TL
    Herberman, RB
    MOLECULAR BIOTECHNOLOGY, 2002, 21 (02) : 161 - 170
  • [2] ADHESION CHARACTERISTICS OF HUMAN INTERLEUKIN-2-ACTIVATED NATURAL-KILLER-CELLS
    MELDER, RJ
    WALKER, E
    HERBERMAN, RB
    WHITESIDE, TL
    CELLULAR IMMUNOLOGY, 1991, 132 (01) : 177 - 192
  • [3] Cancer immunotherapy with interleukin-2-activated natural killer cells
    Per H. Basse
    Theresa L. Whiteside
    Ronald B. Herberman
    Molecular Biotechnology, 2002, 21 : 161 - 170
  • [4] EFFECTS OF INTERLEUKIN-2 AND INTERLEUKIN-2-ACTIVATED CELLS ON INVITRO MYELOPOIESIS
    CLERIGUE, M
    PISA, P
    TSAI, L
    HANSON, M
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1990, 81 (03): : 459 - 465
  • [5] Differential expression of chemokine receptors in natural killer cells and interleukin-2-activated natural killer cells
    Inngjerdingen, M
    Damaj, B
    Maghazachi, AA
    FASEB JOURNAL, 2000, 14 (06): : A1021 - A1021
  • [6] Interleukin-2, interleukin-15, and their roles in human natural killer cells
    Becknell, B
    Caligiuri, MA
    ADVANCES IN IMMUNOLOGY, VOL 86, 2005, 86 : 209 - 239
  • [7] INTERLEUKIN-2-ACTIVATED KILLER-CELLS ARE PHENOTYPICALLY HETEROGENEOUS
    DAMLE, NK
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1987, 6 (02): : 218 - 218
  • [8] TUMORICIDAL EFFECT OF INTERLEUKIN-2-ACTIVATED KILLER CELLS IN CANINES
    JARDINE, JH
    JACKSON, HJ
    LOTZOVA, E
    SAVARY, CA
    SMALL, SM
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1989, 21 (02) : 153 - 160
  • [9] INTERACTION OF RECOMBINANT INTERFERONS WITH RECOMBINANT INTERLEUKIN-2 - DIFFERENTIAL-EFFECTS ON NATURAL-KILLER CELL-ACTIVITY AND INTERLEUKIN-2-ACTIVATED KILLER-CELLS
    BRUNDA, MJ
    TARNOWSKI, D
    DAVATELIS, V
    INTERNATIONAL JOURNAL OF CANCER, 1986, 37 (05) : 787 - 793
  • [10] TUMORICIDAL EFFECT OF INTERLEUKIN-2-ACTIVATED KILLER CELLS IN CANINES
    JARDINE, JH
    JACKSON, HJ
    LOTZOVA, E
    SAVARY, CA
    SMALL, SM
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 531 - 531